Christopher Collette
YOU?
Author Swipe
View article: COGNITIVE INTRAINDIVIDUAL VARIABILITY IN ADULTS WITH AND WITHOUT HIV-ASSOCIATED NEUROCOGNITIVE DISORDER
COGNITIVE INTRAINDIVIDUAL VARIABILITY IN ADULTS WITH AND WITHOUT HIV-ASSOCIATED NEUROCOGNITIVE DISORDER Open
Cognitive intra-individual variability (IIV) is a sensitive marker of reduced top-down cognitive control related to neuropathology and increases with age. Prior work has shown increased cognitive IIV in people living with HIV (PLWH). For t…
View article: 30 Hippocampal Internal Architecture Subfield Volumes Associated with Systematic Inflammatory Biomarkers in Multiple Sclerosis
30 Hippocampal Internal Architecture Subfield Volumes Associated with Systematic Inflammatory Biomarkers in Multiple Sclerosis Open
Objective: Multiple Sclerosis (MS) affects up to 500,000 adults in the United States, with cognitive impairment present in 45%-65% of people. Studies showed hippocampal atrophy in MS, but the underlying mechanisms remain unknown. Inflammat…
View article: 31 Finding the Link Between Inflammatory Biomarkers and Cognitive Functioning in People with Multiple Sclerosis
31 Finding the Link Between Inflammatory Biomarkers and Cognitive Functioning in People with Multiple Sclerosis Open
Objective: To investigate the relationship between systematic inflammatory biomarkers and cognition in patients with Multiple Sclerosis (MS). Participants and Methods: We recruited 36 patients diagnosed with MS (31 with relapsing-remitting…
View article: 49 Subjective and Objective Psychophysical Olfactory Dysfunction in Men Living with HIV
49 Subjective and Objective Psychophysical Olfactory Dysfunction in Men Living with HIV Open
Objective: Olfactory dysfunction can influence nutritional intake, the detection of environmental hazards, and quality of life. Prior research has found discordance between subjective and objective measures of olfaction. In people living w…
View article: Cognitive intra-individual variability in breast cancer survivors: A systematic review
Cognitive intra-individual variability in breast cancer survivors: A systematic review Open
Subjective and objective cognitive impairments in Breast Cancer Survivors (BCS) often do not correlate. One important contribution to the reported disparities may be the reliance on mean-based cognitive performance. Cognitive intra-individ…
View article: Brain and Systemic Inflammation in De Novo Parkinson's Disease
Brain and Systemic Inflammation in De Novo Parkinson's Disease Open
Objective To assess the presence of brain and systemic inflammation in subjects newly diagnosed with Parkinson's disease (PD). Background Evidence for a pathophysiologic role of inflammation in PD is growing. However, several key gaps rema…
View article: Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls
Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls Open
Objective Cognitive impairment in primary and metastatic brain cancers has been well-documented. However, there is a lack of research comparing the cognitive profiles of people with non-central nervous system (CNS) metastatic cancer versus…
View article: Brain and systemic inflammation in <i>de novo</i> Parkinson’s disease
Brain and systemic inflammation in <i>de novo</i> Parkinson’s disease Open
Objective To assess the presence of brain and systemic inflammation in subjects newly diagnosed with Parkinson’s disease (PD). Background Evidence for a pathophysiologic role of inflammation in PD is growing. However, several key gaps rema…
View article: A-158 Levels of Systemic Inflammation is Associated with Cognitive Function in People with Multiple Sclerosis
A-158 Levels of Systemic Inflammation is Associated with Cognitive Function in People with Multiple Sclerosis Open
Objective: To investigate the relationship between systematic inflammatory biomarkers and cognition in patients with Multiple Sclerosis (MS). Method: We recruited 36 patients diagnosed with MS (31 with relapsing-remitting and 5 with progre…